Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic Opportunities

Pancreatic ductal adenocarcinoma (PDAC) is one of the malignancies with the worst prognosis despite a decade of efforts. Up to eighty percent of patients are managed at late stages with metastatic disease, in part due to a lack of diagnosis. The effectiveness of PDAC therapies is challenged by the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Dardare, Julie, Witz, Andréa, Merlin, Jean-Louis, Bochnakian, Agathe, Toussaint, Paul, Gilson, Pauline, Harlé, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399337/
https://www.ncbi.nlm.nih.gov/pubmed/34451837
http://dx.doi.org/10.3390/ph14080740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399337/
https://www.ncbi.nlm.nih.gov/pubmed/34451837
http://dx.doi.org/10.3390/ph14080740

Ejemplares similares